Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
“We don’t know how long the shutdown is going to continue,” says the association’s President and CEO Scott Whitaker.
Device companies will need to assess their business model in order to compete in an outcomes-based reimbursement environment.
The Senate vote is good news for industry, which has fought against the tax for years.
With an established base of medtech companies and a strong workforce, Ireland remains a key player in the global supply chain.
Expect to see slow growth and more mergers & acquisitions.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.
As the agency continues to try to do more with fewer resources, taking additional risks is imperative to move forward.
The winner will be named at the AdvaMed 2015 conference in San Diego next month.
The bill has received bipartisan support for removing barriers and accelerating innovation in medical devices, drugs and biologics.